Clinical Trial Update: Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating treatment for nasal and nasal-type NK/T-cell lymphoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal and Nasal-type Nk T-cell Lymphoma

Snippet

Sponsor: Mingzhi Zhang | Conditions: Nasal and Nasal-type NK/T-cell Lymphoma | Phase 4 | Status: UNKNOWN